tak-385 and Pain

tak-385 has been researched along with Pain* in 3 studies

3 other study(ies) available for tak-385 and Pain

Article	Year
Relugolix combination therapy for endometriosis pain. Lancet (London, England), 2022, 06-18, Volume: 399, Issue:10343 Topics: Drug Therapy, Combination; Endometriosis; Female; Humans; Pain; Phenylurea Compounds; Pyrimidinones	2022
Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials: Correction. Obstetrics and gynecology, 2022, 07-01, Volume: 140, Issue:1 Topics: Female; Freedom; Humans; Leiomyoma; Pain; Phenylurea Compounds; Pyrimidinones; Randomized Controlled Trials as Topic; Uterine Neoplasms	2022
Short-term relugolix treatment for fibroid-related pain: where do we go from here? Fertility and sterility, 2019, Volume: 112, Issue:5 Topics: Female; Gonadotropin-Releasing Hormone; Humans; Japan; Leiomyoma; Pain; Phenylurea Compounds; Pyrimidinones	2019